Associated Papers
Molecular profile of Hürthle cell carcinomas: recurrent mutations in the Wnt/β-catenin pathway.
Santana NO et al.
European Journal of Endocrinology, 2020
KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K-MAPK1 inhibition.
Janardhan HP et al.
The Journal of Experimental Medicine, 2020
Select a paper to view details